Risk of coronary events in people with chronic kidney disease compared with those with diabetes: a population-level cohort study (Q39599282)

13 September 2017

Risk of coronary events in people with chronic kidney disease compared with those with diabetes: a population-level cohort study (English)

1 reference

chronic renal insufficiency

13 September 2017

1 reference

Marcello Tonelli

1

0 references

Alberta Kidney Disease Network

series ordinal

9

object named as

Alberta Kidney Disease Network

1 reference

13 September 2017

2

Paul Muntner

1 reference

13 September 2017

8

Brenda R Hemmelgarn

1 reference

13 September 2017

4

Braden J Manns

1 reference

13 September 2017

6

Neesh Pannu

1 reference

13 September 2017

5

Scott Klarenbach

1 reference

13 September 2017

Anita Lloyd

3

1 reference

PubMed ID

22717317

13 September 2017

Matthew T James

series ordinal

7

1 reference

PubMed ID

22717317

13 September 2017

language of work or name

English

0 references

publication date

19 June 2012

1 reference

13 September 2017

1 reference

13 September 2017

380

1 reference

13 September 2017

9844

1 reference

13 September 2017

807-814

1 reference

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report

13 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960572-8

7 January 2021

Diabetes and coronary risk equivalency: what does it mean?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960572-8

7 January 2021

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960572-8

7 January 2021

Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Preventi

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960572-8

7 January 2021

Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960572-8

7 January 2021

Using proteinuria and estimated glomerular filtration rate to classify risk in patients with chronic kidney disease: a cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960572-8

7 January 2021

Overview of the Alberta Kidney Disease Network

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960572-8

7 January 2021

Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960572-8

7 January 2021

Can universal access to health care eliminate health inequities between children of poor and nonpoor families?: A case study of childhood asthma in Alberta.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960572-8

7 January 2021

A multicenter study of the coding accuracy of hospital discharge administrative data for patients admitted to cardiac care units in Ontario

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960572-8

7 January 2021

Coding of stroke and stroke risk factors using international classification of diseases, revisions 9 and 10.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960572-8

7 January 2021

Diabetes in Ontario: determination of prevalence and incidence using a validated administrative data algorithm

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960572-8

7 January 2021

A new equation to estimate glomerular filtration rate

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960572-8

7 January 2021

Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960572-8

7 January 2021

Screening early renal failure: cut-off values for serum creatinine as an indicator of renal impairment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960572-8

7 January 2021

Relation between kidney function, proteinuria, and adverse outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960572-8

7 January 2021

Calibration of serum creatinine in the National Health and Nutrition Examination Surveys (NHANES) 1988-1994, 1999-2004.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960572-8

7 January 2021

Heart disease and stroke statistics--2011 update: a report from the American Heart Association

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960572-8

7 January 2021

Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960572-8

7 January 2021

Impact of diabetes on mortality after the first myocardial infarction. The FINMONICA Myocardial Infarction Register Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960572-8

7 January 2021

Ten-year survival after acute myocardial infarction: comparison of patients with and without diabetes. SPRINT Study Group. Secondary Prevention Reinfarction Israeli Nifedipine Trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960572-8

7 January 2021

Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960572-8

7 January 2021

The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960572-8

7 January 2021

Effect of pravastatin on cardiovascular events in people with chronic kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960572-8

7 January 2021

Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960572-8

7 January 2021

Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960572-8

7 January 2021

Prediction of Coronary Heart Disease Using Risk Factor Categories

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960572-8

7 January 2021

The impact of reclassifying moderate CKD as a coronary heart disease risk equivalent on the number of US adults recommended lipid-lowering treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960572-8

7 January 2021

Is diabetes a coronary risk equivalent? Systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960572-8

7 January 2021

Cardiovascular risk among adults with chronic kidney disease, with or without prior myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960572-8

7 January 2021

The case for chronic kidney disease, diabetes mellitus, and myocardial infarction being equivalent risk factors for cardiovascular mortality in patients older than 65 years

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960572-8

7 January 2021

Chronic kidney disease as a predictor of cardiovascular disease (from the Framingham Heart Study)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960572-8

7 January 2021

Chronic kidney disease and mortality risk: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960572-8

7 January 2021

Performance of the chronic kidney disease epidemiology collaboration equation to estimate glomerular filtration rate in diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960572-8

7 January 2021

Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation pronouncedly underestimates glomerular filtration rate in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960572-8

7 January 2021

Comparison of the prevalence and mortality risk of CKD in Australia using the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) Study GFR estimating equations: the AusDiab (Australian Diabetes, Obesity and Lif

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960572-8

7 January 2021

10.1016/S0140-6736(12)60572-8

Identifiers

DOI

1 reference

13 September 2017

1 reference

PubMed ID

22717317